Big Pharma spends billions more on executives and stockholders than on R&D
Briefly

"In other words, these companies are spending more to enrich their own stockholders and CEOs than they are in finding new cures and new treatments," he said.
"We are aware of the many important lifesaving drugs that your companies have produced," said the committee to the CEOs of three pharmaceutical companies.
Read at Ars Technica
[
add
]
[
|
|
]